1
|
Pal S, Yellurkar ML, Das P, Sai Prasanna V, Sarkar S, Gajbhiye RL, Taraphdar AK, Velayutham R, Arumugam S. A network pharmacology, molecular docking and in vitro investigation of Picrorhiza kurroa extract for the treatment of diabetic nephropathy. J Biomol Struct Dyn 2024:1-12. [PMID: 38356141 DOI: 10.1080/07391102.2024.2314259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2023] [Accepted: 01/30/2024] [Indexed: 02/16/2024]
Abstract
Picrorhiza kurroa Royle ex Benth. (P. kurroa/PK/Kutki), a Himalayan herb belonging to the family Scrophulariaceae, is widely known for its hepatoprotective activity. Traditionally, it is found to be effective for upper respiratory tract disorders, kidney and liver problems, dyspepsia and chronic diarrhoea but the mechanism of action is unclear. In this study, the mode of action of P. kurroa for the treatment of diabetic nephropathy (DN) was investigated by network pharmacology, molecular docking and in vitro assays. Numerous databases have been screened and 33 P. kurroa bioactive compounds and 56 targets were identified. The compounds-targets network, targets-pathways network and compounds-targets-pathways network were constructed. The major bioactive compounds include picrorhizaoside D, scrophuloside A, vanillic acid, arvenin I, cinnamic acid, picein, 6-feruloyl catalpol, picroside V, pikuroside, apocynin, picroside I, picroside IV, androsin, cucurbitacin P, boschnaloside, kutkoside, cucurbitacin O, cucurbitacin K, picracin, etc. The potential protein targets identified in this study were MMP1, PRKCA, MMP7, IL18, IL1, TNF, ACE, ASC, CASP1, NLRP3, MAP, KURROA1, mitogen-activated protein kinase (MAPK)14 and MAPK8. In the Database for annotation visualization and integrated discovery (DAVID) pathways and Gene Ontology enrichment analysis, 14 major DN signalling pathways were identified, including MAPK, renin-angiotensin system (RAS), TNF, signal transducer and activator of transcription (JAK-STAT), TLR, vascular endothelial growth factor (VEGF), mTOR, Wnt, Ras, PPARs, NFB, NOD and phosphatidylinositol signalling pathways. A molecular docking study revealed that 32 bioactive compounds of P. kurroa interacted with 14 significant proteins/genes associated with DN. P. kurroa extract was proven to enhance the survival rate of HEK cells significantly. Protein expression analysis using Western blot demonstrated that P. kurroa extract significantly altered the expression of p47phox, p67phox, gp91phox, IL-1 and TGFβ-1. As a result of network pharmacology and docking work, new concepts for discovering bioactive compounds and effective modes of action could be developed. The potential effect of P. kurroa extract on DN disease was evident in the in-vitro studies aided by network pharmacology and molecular docking.Communicated by Ramaswamy H. Sarma.
Collapse
Affiliation(s)
- Shiv Pal
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur, Export Promotion Industrial Park (EPIP), Industrial area Hajipur, Bihar, India
| | - Manoj Limbraj Yellurkar
- National Institute of Pharmaceutical Education and Research (NIPER), Chunilal Bhawan, Kolkata, India
| | - Pamelika Das
- National Institute of Pharmaceutical Education and Research (NIPER), Chunilal Bhawan, Kolkata, India
| | - Vani Sai Prasanna
- National Institute of Pharmaceutical Education and Research (NIPER), Chunilal Bhawan, Kolkata, India
| | - Sulogna Sarkar
- National Institute of Pharmaceutical Education and Research (NIPER), Chunilal Bhawan, Kolkata, India
| | - Rahul L Gajbhiye
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur, Export Promotion Industrial Park (EPIP), Industrial area Hajipur, Bihar, India
- National Institute of Pharmaceutical Education and Research (NIPER), Chunilal Bhawan, Kolkata, India
| | - Amit Kumar Taraphdar
- Department of Dravyaguna (Ayurved Pharmacology) Institute of Post Graduate Ayurvedic Education and Research, Kolkata, India
| | - Ravichandiran Velayutham
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur, Export Promotion Industrial Park (EPIP), Industrial area Hajipur, Bihar, India
- National Institute of Pharmaceutical Education and Research (NIPER), Chunilal Bhawan, Kolkata, India
| | - Somasundaram Arumugam
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER) Hajipur, Export Promotion Industrial Park (EPIP), Industrial area Hajipur, Bihar, India
- National Institute of Pharmaceutical Education and Research (NIPER), Chunilal Bhawan, Kolkata, India
| |
Collapse
|
2
|
Moinuddin SK, Gajbhiye RL, Mehta P, Sarmah B, Murty US, Ravichandiran V, Samudrala PK, Alexander A, Kumar P. UHPLC-DAD Method Development and Validation: Degradation Kinetic, Stress Studies of Farnesol and Characterization of Degradation Products Using LC-QTOF-ESI-MS with in silico Pharmacokinetics and Toxicity Predictions. J Chromatogr Sci 2021; 60:817-831. [PMID: 34849633 DOI: 10.1093/chromsci/bmab127] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2021] [Revised: 08/12/2021] [Accepted: 10/15/2021] [Indexed: 11/13/2022]
Abstract
Farnesol (FAR) is a sesquiterpene molecule with high lipophilicity that has antibacterial and other pharmacological properties along with broad nutritional values with high commercial values. Although having potential, FAR stability behavior and degradation kinetics are not available in the literature. Hence, it is very essential to develop a simple, rapid, accurate, precise, robust, cheap UHPLC-DAD method for FAR. It was also proposed to study mechanistic insights into FAR under different degradation conditions. Therefore, we hypothesized to do systematic stability studies along with degradation kinetic and accelerated stability studies. The developed method was validated. FAR was studied for stress studies, degradation kinetics and ADMET prediction of degradants. Degradation products were characterized using LC-QTOF-ESI-MS. Developed method consists of an isocratic mobile phase with a wavelength of 215 nm. The percent recoveries for FAR were observed within the acceptance limit of 98-102%. The eight major degradation products were formed during stress studies. FAR follows first-order degradation kinetics. FAR and all degradants were found to have more than 75% good human oral absorption, and are non-toxic. FAR UHPLC-DAD method was developed, validated and performed stability studies to know the possible degradation pattern along with degradation kinetic studies.
Collapse
Affiliation(s)
- Shaik Khaja Moinuddin
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, SilaKatamur (Halugurisuk), Changsari, Kamrup, Assam 781101, India
| | - Rahul L Gajbhiye
- Central Instrumentation Facility, National Institute of Pharmaceutical Education and Research, Chunilal Bhawan (Adjacent to BCPL), 168, Maniktala Main Road, P.O. Bengal Chemicals, P.S. Phoolbagan, Kolkata, West Bengal 700054, India
| | - Pakhuri Mehta
- Faculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Warsaw 02-093, Poland
| | - Bhaskar Sarmah
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, SilaKatamur (Halugurisuk), Changsari, Kamrup, Assam 781101, India.,BioNEST, Incubation Centre, National Institute of Pharmaceutical Education and Research (NIPER-Guwahati), Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India, Sila Katamur (Halugurisuk), Changsari, Kamrup, Guwahati, Assam 781101, India
| | - Upadhyayula Suryanarayana Murty
- National Institute of Pharmaceutical Education and Research, Guwahati, SilaKatamur (Halugurisuk), Changsari, Kamrup, Assam 781101, India
| | - V Ravichandiran
- National Institute of Pharmaceutical Education and Research, Chunilal Bhawan (Adjacent to BCPL), 168, Maniktala Main Road, P.O. Bengal Chemicals, P.S. Phoolbagan, Kolkata, West Bengal 700054, India
| | - Pavan Kumar Samudrala
- Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India, Sila Katamur (Halugurisuk), Changsari, Kamrup, Guwahati, Assam 781101, India
| | - Amit Alexander
- Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India, Sila Katamur (Halugurisuk), Changsari, Kamrup, Guwahati, Assam 781101, India
| | - Pramod Kumar
- Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research, Guwahati, SilaKatamur (Halugurisuk), Changsari, Kamrup, Assam 781101, India
| |
Collapse
|
3
|
Ghosh S, Dutta N, Banerjee P, Gajbhiye RL, Sareng HR, Kapse P, Pal S, Burdelya L, Mandal NC, Ravichandiran V, Bhattacharjee A, Kundu GC, Gudkov AV, Pal M. Induction of monoamine oxidase A-mediated oxidative stress and impairment of NRF2-antioxidant defence response by polyphenol-rich fraction of Bergenia ligulata sensitizes prostate cancer cells in vitro and in vivo. Free Radic Biol Med 2021; 172:136-151. [PMID: 34097996 DOI: 10.1016/j.freeradbiomed.2021.05.037] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/11/2021] [Revised: 05/14/2021] [Accepted: 05/27/2021] [Indexed: 12/13/2022]
Abstract
Prostate cancer (PCa) is a major cause of mortality and morbidity in men. Available therapies yield limited outcome. We explored anti-PCa activity in a polyphenol-rich fraction of Bergenia ligulata (PFBL), a plant used in Indian traditional and folk medicine for its anti-inflammatory and antineoplastic properties. PFBL constituted of about fifteen different compounds as per LCMS analysis induced apoptotic death in both androgen-dependent LNCaP and androgen-refractory PC3 and DU145 cells with little effect on NKE and WI38 cells. Further investigation revealed that PFBL mediates its function through upregulating ROS production by enhanced catalytic activity of Monoamine oxidase A (MAO-A). Notably, the differential inactivation of NRF2-antioxidant response pathway by PFBL resulted in death in PC3 versus NKE cells involving GSK-3β activity facilitated by AKT inhibition. PFBL efficiently reduced the PC3-tumor xenograft in NOD-SCID mice alone and in synergy with Paclitaxel. Tumor tissues in PFBL-treated mice showed upregulation of similar mechanism of cell death as observed in isolated PC3 cells i.e., elevation of MAO-A catalytic activity, ROS production accompanied by activation of β-TrCP-GSK-3β axis of NRF2 degradation. Blood counts, liver, and splenocyte sensitivity analyses justified the PFBL safety in the healthy mice. To our knowledge this is the first report of an activity that crippled NRF2 activation both in vitro and in vivo in response to MAO-A activation. Results of this study suggest the development of a novel treatment protocol utilizing PFBL to improve therapeutic outcome for patients with aggressive PCa which claims hundreds of thousands of lives each year.
Collapse
Affiliation(s)
- Suvranil Ghosh
- Division of Molecular Medicine, Bose Institute, Kolkata, India
| | - Naibedya Dutta
- Division of Molecular Medicine, Bose Institute, Kolkata, India
| | - Pinaki Banerjee
- Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Center for Cell Science, Savitribai Phule Pune University Campus, Pune, India
| | - Rahul L Gajbhiye
- National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, India
| | | | - Prachi Kapse
- Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Center for Cell Science, Savitribai Phule Pune University Campus, Pune, India
| | - Srabani Pal
- Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA
| | - Lyudmila Burdelya
- Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA
| | | | - Velyutham Ravichandiran
- National Institute of Pharmaceutical Education and Research (NIPER), Hajipur, India; National Institute of Pharmaceutical Education and Research (NIPER), Kolkata, India
| | | | - Gopal C Kundu
- Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Center for Cell Science, Savitribai Phule Pune University Campus, Pune, India
| | - Andrei V Gudkov
- Department of Cell Stress Biology, Roswell Park Cancer Institute, Buffalo, NY, USA
| | - Mahadeb Pal
- Division of Molecular Medicine, Bose Institute, Kolkata, India.
| |
Collapse
|
4
|
Goel N, Gajbhiye RL, Saha M, Nagendra C, Reddy AM, Ravichandiran V, Das Saha K, Jaisankar P. A comparative assessment of in vitro cytotoxic activity and phytochemical profiling of Andrographis nallamalayana J.L.Ellis and Andrographis paniculata (Burm. f.) Nees using UPLC-QTOF-MS/MS approach. RSC Adv 2021; 11:35918-35936. [PMID: 35492784 PMCID: PMC9043227 DOI: 10.1039/d1ra07496b] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2021] [Accepted: 10/18/2021] [Indexed: 12/15/2022] Open
Abstract
Andrographis paniculata (Burm. f.) Nees and Andrographis nallamalayana J.L.Ellis have traditionally been used to treat various ailments such as mouth ulcers, intermittent fever, inflammation, snake bite. This study compares the comparative in vitro cytotoxic activity, and phytochemical profiling of methanol extract of A. nallamalayana (ANM) and A. paniculata (APM). UPLC-ESI-QTOF-MS/MS analysis has been performed. The cytotoxic activity of crude methanol extracts were evaluated against three different cancer cell lines (HCT 116, HepG2, and A549 cell line). Both plants' extract exhibited significant cytotoxic activity against tested cell lines in a dose-dependent manner. IC50 of ANM and APM in HCT 116 cell was 11.71 ± 2.48 μg ml−1 and 45.32 ± 0.86 μg ml−1 and in HepG2 cell line was 15.65 ± 2.25 μg ml−1 and 60.32 ± 1.05 μg ml−1 respectively. Cytotoxicity of these two extracts was comparatively similar in A549 cells. ANM induced cytotoxicity involved programmed cell death, externalisation of phosphatidylserine, ROS generation, up-regulation and down-regulation of major apoptotic markers. HRMS analysis of ANM and APM resulted in the identification of 59 and 42 compounds, respectively. Further, using the MS/MS fragmentation approach, 20 compounds, of which 18 compounds were identified for the first time from ANM, which belongs to phenolic acids, flavonoids, and their glycosides. Three known compounds, echioidinin, skullcapflavone I and 5,2′,6′-trihydroxy-7-methoxyflavone 2′-O-β-d-glucopyranoside, were isolated from A. nallamalayana and their crystal structures were reported for the first time. Subsequently, seven major compounds were identified in A. nallamalayana by direct comparison (retention time and UV-spectra) with authentic commercial standards and isolated compounds using HPLC-UV analysis. The cytotoxicity of phytochemicals from both the plants using in silico tools also justify their in vitro cytotoxic activity. It is the first report on the comparative characterisation of phytochemicals present in the methanolic extract of both the species of Andrographis, along with the cytotoxic activity of A. nallamalayana. A comparative study of two Andrographis species have been done, and it was found that Andrographis nallamalayana J.L.Ellis is phytochemically and biologically different from Andrographis paniculata (Burm. f.) Nees.![]()
Collapse
Affiliation(s)
- Narender Goel
- Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER-Kolkata), Chunilal Bhawan, 168, Maniktala Main Road, 700054, Kolkata, India
- Laboratory of Catalysis and Chemical Biology, Department of Organic and Medicinal Chemistry, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata-700032, India
| | - Rahul L. Gajbhiye
- Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER-Kolkata), Chunilal Bhawan, 168, Maniktala Main Road, 700054, Kolkata, India
| | - Moumita Saha
- Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Jadavpur, Kolkata-700032, India
| | - Chennuru Nagendra
- Department of Botany, Yogi Vemana University, Vemanapuram, Kadapa, Andhra Pradesh 516005, India
| | | | - V. Ravichandiran
- Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER-Kolkata), Chunilal Bhawan, 168, Maniktala Main Road, 700054, Kolkata, India
| | - Krishna Das Saha
- Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4, Raja S. C. Mullick Road, Jadavpur, Kolkata-700032, India
| | - Parasuraman Jaisankar
- Laboratory of Catalysis and Chemical Biology, Department of Organic and Medicinal Chemistry, CSIR-Indian Institute of Chemical Biology, 4 Raja S. C. Mullick Road, Kolkata-700032, India
| |
Collapse
|
5
|
More GS, Thomas AB, Chitlange SS, Nanda RK, Gajbhiye RL. Nitrogen Mustards as Alkylating Agents: A Review on Chemistry, Mechanism of Action and Current USFDA Status of Drugs. Anticancer Agents Med Chem 2020; 19:1080-1102. [PMID: 30834842 DOI: 10.2174/1871520619666190305141458] [Citation(s) in RCA: 20] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2018] [Revised: 12/20/2018] [Accepted: 02/16/2019] [Indexed: 12/31/2022]
Abstract
BACKGROUND & OBJECTIVE Nitrogen mustard derivatives form one of the major classes of anti-cancer agents in USFDA approved drugs list. These are polyfunctional alkylating agents which are distinguished by a unique mechanism of adduct formation with DNA involving cross-linking between guanine N-7 of one strand of DNA with the other. The generated cross-linking is irreversible and leads to cell apoptosis. Hence it is of great interest to explore this class of anticancer alkylating agents. METHODS An exhaustive list of reviews, research articles, patents, books, patient information leaflets, and orange book is presented and the contents related to nitrogen mustard anti-cancer agents have been reviewed. Attempts are made to present synthesis schemes in a simplified manner. The mechanism of action of the drugs and their side effects are also systematically elaborated. RESULTS This review provides a platform for understanding all aspects of such drugs right from synthesis to their mechanism of action and side effects, and lists USFDA approved ANDA players among alkylating anticancer agents in the current market. CONCLUSION Perusing this article, generic scientists will be able to access literature information in this domain easily to gain insight into the nitrogen mustard alkylating agents for further ANDA development. It will help the scientific and research community to continue their pursuit for the design of newer and novel heterocyclic alkylating agents of this class in the coming future.
Collapse
Affiliation(s)
- Ghansham S More
- Department of Pharmaceutical Chemistry, Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Savitribai Phule Pune University, Pune, India
| | - Asha B Thomas
- Department of Pharmaceutical Chemistry, Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Savitribai Phule Pune University, Pune, India
| | - Sohan S Chitlange
- Department of Pharmaceutical Chemistry, Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Savitribai Phule Pune University, Pune, India
| | - Rabindra K Nanda
- Department of Pharmaceutical Chemistry, Dr. D.Y. Patil Institute of Pharmaceutical Sciences and Research, Savitribai Phule Pune University, Pune, India
| | - Rahul L Gajbhiye
- Organic & Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700 032, India
| |
Collapse
|
6
|
Majumder M, Debnath S, Gajbhiye RL, Saikia R, Gogoi B, Samanta SK, Das DK, Biswas K, Jaisankar P, Mukhopadhyay R. Ricinus communis L. fruit extract inhibits migration/invasion, induces apoptosis in breast cancer cells and arrests tumor progression in vivo. Sci Rep 2019; 9:14493. [PMID: 31601896 PMCID: PMC6787038 DOI: 10.1038/s41598-019-50769-x] [Citation(s) in RCA: 37] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2017] [Accepted: 09/10/2019] [Indexed: 12/13/2022] Open
Abstract
Medicinal plant-based therapies can be important for treatment of cancer owing to high efficiency, low cost and minimal side effects. Here, we report the anti-cancer efficacy of Ricinus communis L. fruit extract (RCFE) using estrogen positive MCF-7 and highly aggressive, triple negative MDA-MB-231 breast cancer cells. RCFE induced cytotoxicity in these cells in dose and time-dependent manner. It also demonstrated robust anti-metastatic activity as it significantly inhibited migration, adhesion, invasion and expression of matrix metalloproteinases (MMPs) 2 and 9 in both cell lines. Further, flow cytometry analysis suggested RCFE-mediated induction of apoptosis in these cells. This was supported by attenuation of anti-apoptotic Bcl-2, induction of pro-apoptotic Bax and caspase-7 expressions as well as PARP cleavage upon RCFE treatment. RCFE (0.5 mg/Kg body weight) treatment led to significant reduction in tumor volume in 4T1 syngeneic mouse model. HPLC and ESI-MS analysis of active ethyl acetate fraction of RCFE detected four compounds, Ricinine, p-Coumaric acid, Epigallocatechin and Ricinoleic acid. Individually these compounds showed cytotoxic and migration-inhibitory activities. Overall, this study for the first time demonstrates the anti-cancer efficacy of the fruit extract of common castor plant which can be proposed as a potent candidate for the treatment of breast cancer.
Collapse
Affiliation(s)
- Munmi Majumder
- Cellular, Molecular and Environmental Biotechnology Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, 784028, Assam, India
| | - Shibjyoti Debnath
- Division of Molecular Medicine, Bose Institute, P1/12 CIT Road, Scheme VIIM, Kolkata, 700054, India
| | - Rahul L Gajbhiye
- Laboratory of Catalysis and Chemical Biology, Organic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, Jadavpur, Kolkata, 700032, India
| | - Rimpi Saikia
- Cellular, Molecular and Environmental Biotechnology Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, 784028, Assam, India
| | - Bhaskarjyoti Gogoi
- Institute of Advanced Study in Science and Technology, Vigyan Path, Paschim Boragaon, Guwahati, Assam, 781035, India
- Department of Biotechnology Royal School of Bio-Sciences Royal Global University, Guwahati, Assam, 781035, India
| | - Suman Kumar Samanta
- Institute of Advanced Study in Science and Technology, Vigyan Path, Paschim Boragaon, Guwahati, Assam, 781035, India
| | - Deepjyoti K Das
- Cellular, Molecular and Environmental Biotechnology Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, 784028, Assam, India
| | - Kaushik Biswas
- Division of Molecular Medicine, Bose Institute, P1/12 CIT Road, Scheme VIIM, Kolkata, 700054, India
| | - Parasuraman Jaisankar
- Laboratory of Catalysis and Chemical Biology, Organic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, Jadavpur, Kolkata, 700032, India
| | - Rupak Mukhopadhyay
- Cellular, Molecular and Environmental Biotechnology Laboratory, Department of Molecular Biology and Biotechnology, Tezpur University, Tezpur, 784028, Assam, India.
| |
Collapse
|
7
|
Banerjee S, Mukherjee N, Gajbhiye RL, Mishra S, Jaisankar P, Datta S, Das Saha K. Intracellular anti-leishmanial effect of Spergulin-A, a triterpenoid saponin of Glinus oppositifolius. Infect Drug Resist 2019; 12:2933-2942. [PMID: 31571946 PMCID: PMC6756365 DOI: 10.2147/idr.s211721] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2019] [Accepted: 08/06/2019] [Indexed: 12/19/2022] Open
Abstract
Background Many of present chemotherapeutics are inadequate and also resistant against visceral leishmaniasis (VL), an immunosuppressive ailment caused by Leishmania donovani. Despite the interest in plant-based drug development, no antileishmanial drugs from plant source are currently available. Glinus oppositifolius had been reported in favor of being immune modulators along with other traditional uses. Novel anti-VL therapies can rely on host immune-modulation with associated leishmanicidal action. Objective Discovery of novel plant-based antileishmanial compound from G. oppositifolius having permissible side effects. Methods With this rationale, an n-BuOH fraction of the methanolic extract of the plant and obtained triterpenoid saponin Spergulin-A were evaluated against acellular and intracellular L. donovani. Immunostimulatory activity of them was confirmed by elevated TNF-α and extracellular NO production from treated MФs and was found nontoxic to the host cells. Identification and structure confirmation for isolated Spergulin-A was performed by ESI-MS,13C, and 1H NMR. Results Spergulin-A was found ineffective against the acellular forms while, against the intracellular parasites at 30 μg/mL, the reduction was 92.6% after 72 hrs. Spergulin-A enhanced ROS and nitric oxide (NO) release and changes in Gp91-phox, i-NOS, and pro and anti-inflammatory cytokines elaborated its intracellular anti-leishmanial activity. Conclusion The results supported that G. oppositifolius and Spergulin-A can potentiate new lead molecules for the development of alternative drugs against VL.
Collapse
Affiliation(s)
- Saswati Banerjee
- Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India
| | - Niladri Mukherjee
- Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India
| | - Rahul L Gajbhiye
- Organic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India
| | - Snehasis Mishra
- Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India
| | - Parasuraman Jaisankar
- Organic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India
| | - Sriparna Datta
- Department of Chemical Technology, University of Calcutta, Kolkata 700009, India
| | - Krishna Das Saha
- Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, Kolkata 700032, India
| |
Collapse
|
8
|
Nahak P, Gajbhiye RL, Karmakar G, Guha P, Roy B, Besra SE, Bikov AG, Akentiev AV, Noskov BA, Nag K, Jaisankar P, Panda AK. Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines. Pharm Res 2018; 35:198. [PMID: 30151753 DOI: 10.1007/s11095-018-2469-3] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/16/2018] [Accepted: 07/30/2018] [Indexed: 12/30/2022]
Abstract
PURPOSE Orcinol glucoside (OG) - loaded nanostructured lipid carrier (NLC), coated with polyethylene glycol-25/55-stearate (PEG-25/55-SA), were explored for delivering OG to improve in vitro cytotoxicity against gastrointestinal tract (GIT), colon and hepatoma carcinoma cell lines. It is being expected that the PEGylated formulations would possess the sustainability in withstanding the adverse physiological extremities like the most significant metabolic activities and phase I / II enzymatic activities in the intestines. METHODS NLCs were prepared using tristearin, oleic acid and PEG-25/55-stearate by hot homogenization-ultrasonic dispersion; characterized by DLS, TEM, SEM, AFM, entrapment efficiency and drug loading capacity studies. RESULTS NLC diameter ranged from 160 to 230 nm with negative zeta potential of -8 to -20 mV. TEM/SEM and AFM studies suggest spherical and smooth surface morphologies. Differential scanning calorimetry studies reveal the loss of crystallinity when OG was incorporated into the NLC. NLCs showed initial burst release, followed by sustained release of OG. PEG-NLC exhibited superior anticancer activity against GIT and also in hepatoma cancer cell lines. CONCLUSIONS This is the first report demonstrating a practical approach for possible oral delivery of OG in GIT and targeting hepatoma cancer, warranting further in vivo studies for superior management of GIT cancer.
Collapse
Affiliation(s)
- Prasant Nahak
- Department of Chemistry, University of North Bengal, Darjeeling, West Bengal, 734 013, India
| | - Rahul L Gajbhiye
- Organic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, 4, Raja S. C. Mullcik Road, Jadavpur, Kolkata, West Bengal, 700032, India
| | - Gourab Karmakar
- Department of Chemistry, University of North Bengal, Darjeeling, West Bengal, 734 013, India
| | - Pritam Guha
- Department of Chemistry, University of North Bengal, Darjeeling, West Bengal, 734 013, India
| | - Biplab Roy
- Department of Chemistry, University of North Bengal, Darjeeling, West Bengal, 734 013, India
| | - Shila Elizabeth Besra
- Cancer Biology and Inflammatory Disorder Division, CSIR-Indian Institute of Chemical Biology, 4, Raja S. C. Mullcik Road, Jadavpur, Kolkata, West Bengal, 700032, India
| | - Alexey G Bikov
- Department of Colloid Chemistry, Saint Petersburg State University, Universitetsky pr. 26, Saint Petersburg, 198504, Russia
| | - Alexander V Akentiev
- Department of Colloid Chemistry, Saint Petersburg State University, Universitetsky pr. 26, Saint Petersburg, 198504, Russia
| | - Boris A Noskov
- Department of Colloid Chemistry, Saint Petersburg State University, Universitetsky pr. 26, Saint Petersburg, 198504, Russia
| | - Kaushik Nag
- Department of Biochemistry, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada
| | - Parasuraman Jaisankar
- Organic and Medicinal Chemistry Division, CSIR-Indian Institute of Chemical Biology, 4, Raja S. C. Mullcik Road, Jadavpur, Kolkata, West Bengal, 700032, India.
| | - Amiya Kumar Panda
- Department of Chemistry and Chemical Technology, Vidyasagar University, Midnapore, West Bengal, 721 102, India.
| |
Collapse
|
9
|
Vinayagam J, Gajbhiye RL, Mandal L, Arumugam M, Achari A, Jaisankar P. Substituted furans as potent lipoxygenase inhibitors: Synthesis, in vitro and molecular docking studies. Bioorg Chem 2017; 71:97-101. [PMID: 28143657 DOI: 10.1016/j.bioorg.2017.01.016] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2016] [Revised: 12/29/2016] [Accepted: 01/20/2017] [Indexed: 11/18/2022]
Abstract
A number of 2-methyl-4-(2-oxo-2-phenyl-ethyl)-5-phenyl-furan-3-carboxylic acid alkyl ester derivatives (3a-j) were synthesized and evaluated for their in vitro inhibitory activity on soybean lipoxygenase enzyme. Among the screened compounds, 5-(4-bromo-phenyl)-4-[2-(4-bromo-phenyl)-2-oxo-ethyl]-2-methyl-furan-3-carboxylic acid methyl ester (3g) has been found to exhibit potent inhibitory activity with IC5012.8μM using nordihydroguaiaretic acid (NDGA) as standard. Molecular modeling was employed for better understanding of the binding between compounds and soybean lipoxygenase enzyme. The predicted binding energy values correlated well with the observed in vitro data.
Collapse
Affiliation(s)
- Jayaraman Vinayagam
- Laboratory of Catalysis and Chemical Biology, Department of Organic and Medicinal Chemistry, CSIR - Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Kolkata 700 032, India
| | - Rahul L Gajbhiye
- Laboratory of Catalysis and Chemical Biology, Department of Organic and Medicinal Chemistry, CSIR - Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Kolkata 700 032, India
| | - Likhit Mandal
- Laboratory of Catalysis and Chemical Biology, Department of Organic and Medicinal Chemistry, CSIR - Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Kolkata 700 032, India
| | - Meyyappan Arumugam
- School of Environmental Studies, Jadavpur University, Kolkata 700 032, India
| | - Anushree Achari
- Laboratory of Catalysis and Chemical Biology, Department of Organic and Medicinal Chemistry, CSIR - Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Kolkata 700 032, India
| | - Parasuraman Jaisankar
- Laboratory of Catalysis and Chemical Biology, Department of Organic and Medicinal Chemistry, CSIR - Indian Institute of Chemical Biology, 4, Raja S.C. Mullick Road, Kolkata 700 032, India.
| |
Collapse
|